BioCentury
ARTICLE | Company News

BioSyntech, Kuhnil Pharma Co. Ltd. deal

February 20, 2006 8:00 AM UTC

BSY granted Kuhnil exclusive Korean marketing and distribution rights to BST-CarGel to repair localized cartilage regions and BST-InPod to treat chronic heal pain. Kuhnil purchased 1.5 million BSY sh...